Literature DB >> 17617769

Hypertensive pregnancy disorders: current concepts.

Steven J Wagner1, Snezana Barac, Vesna D Garovic.   

Abstract

Hypertensive pregnancy disorders complicate 10% of all pregnancies and cover a spectrum of conditions, namely preeclampsia, eclampsia, and chronic and gestational hypertension. Preeclampsia is a pregnancy-specific disorder clinically characterized by hypertension and proteinuria that occurs after 20 weeks of gestation. It remains a leading cause of both fetal and maternal morbidity and mortality worldwide. Traditionally, hypertensive pregnancy disorders were considered not to have any long-term impact on mothers' cardiovascular health; however, recent studies consistently have supported the role of hypertension in pregnancy as a risk factor for cardiovascular disease later in life. Therefore, improved screening, and preventive and treatment strategies may not only optimize management of hypertensive pregnancy disorders, but may have a long-term impact on women's cardiovascular events and outcomes years after the affected pregnancies. This article will provide a brief review of hypertensive pregnancy disorders and important recent discoveries regarding their pathogeneses, while focusing on current diagnostic and treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617769      PMCID: PMC8109890          DOI: 10.1111/j.1524-6175.2007.06695.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  16 in total

Review 1.  Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review.

Authors:  Mariana Widmer; José Villar; Ariela Benigni; Agustin Conde-Agudelo; S Ananth Karumanchi; Marshall Lindheimer
Journal:  Obstet Gynecol       Date:  2007-01       Impact factor: 7.661

2.  Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia.

Authors:  Vesna D Garovic; Steven J Wagner; Lydia M Petrovic; Catherine E Gray; Pauline Hall; Hikaru Sugimoto; Raghu Kalluri; Joseph P Grande
Journal:  Nephrol Dial Transplant       Date:  2007-01-25       Impact factor: 5.992

3.  Vitamins C and E and the risks of preeclampsia and perinatal complications.

Authors:  Alice R Rumbold; Caroline A Crowther; Ross R Haslam; Gustaaf A Dekker; Jeffrey S Robinson
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

4.  Trial of calcium to prevent preeclampsia.

Authors:  R J Levine; J C Hauth; L B Curet; B M Sibai; P M Catalano; C D Morris; R DerSimonian; J R Esterlitz; E G Raymond; D E Bild; J D Clemens; J A Cutler
Journal:  N Engl J Med       Date:  1997-07-10       Impact factor: 91.245

5.  Urinary podocyte excretion as a marker for preeclampsia.

Authors:  Vesna D Garovic; Steven J Wagner; Stephen T Turner; David W Rosenthal; William J Watson; Brian C Brost; Carl H Rose; Larisa Gavrilova; Paula Craigo; Kent R Bailey; Johannes Achenbach; Mario Schiffer; Joseph P Grande
Journal:  Am J Obstet Gynecol       Date:  2007-04       Impact factor: 8.661

6.  Major congenital malformations after first-trimester exposure to ACE inhibitors.

Authors:  William O Cooper; Sonia Hernandez-Diaz; Patrick G Arbogast; Judith A Dudley; Shannon Dyer; Patricia S Gideon; Kathi Hall; Wayne A Ray
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

7.  Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Authors:  S Caritis; B Sibai; J Hauth; M D Lindheimer; M Klebanoff; E Thom; P VanDorsten; M Landon; R Paul; M Miodovnik; P Meis; G Thurnau
Journal:  N Engl J Med       Date:  1998-03-12       Impact factor: 91.245

8.  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  2000-07       Impact factor: 8.661

9.  Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Authors:  B M Sibai; M Lindheimer; J Hauth; S Caritis; P VanDorsten; M Klebanoff; C MacPherson; M Landon; M Miodovnik; R Paul; P Meis; M Dombrowski
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

10.  Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.

Authors:  Douglas Altman; Guillermo Carroli; Lelia Duley; Barbara Farrell; Jack Moodley; James Neilson; David Smith
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

View more
  20 in total

Review 1.  Maternal Microbiome and Pregnancy Outcomes That Impact Infant Health: A Review.

Authors:  Anne L Dunlop; Jennifer G Mulle; Erin P Ferranti; Sara Edwards; Alexis B Dunn; Elizabeth J Corwin
Journal:  Adv Neonatal Care       Date:  2015-12       Impact factor: 1.968

2.  Relationship Between Pregnancy Complications and Psychiatric Disorders: A Population-Based Study With a Matched Control Group.

Authors:  Christina D Kang-Yi; Sara L Kornfield; C Neill Epperson; David S Mandell
Journal:  Psychiatr Serv       Date:  2017-11-15       Impact factor: 3.084

3.  Maternal Weight, Snoring, and Hypertension: Potential Pathways of Associations.

Authors:  Galit Levi Dunietz; Kerby Shedden; Lynda D Lisabeth; Marjorie C Treadwell; Louise M O'Brien
Journal:  Am J Hypertens       Date:  2018-09-11       Impact factor: 2.689

4.  Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors.

Authors:  Hadi Ramadan; Sarosh Rana; Ariel Mueller; Surichhya Bajracharya; Dongsheng Zhang; Saira Salahuddin; Rabab Nasim; Joana Lopes Perdigao; Mohammed Minhaj; Avery Tung; Zolt Arany; Sajid Shahul
Journal:  Hypertens Pregnancy       Date:  2017-03-01       Impact factor: 2.108

5.  Postpartum healthcare after gestational diabetes and hypertension.

Authors:  Deborah B Ehrenthal; Kristin Maiden; Stephanie Rogers; Amy Ball
Journal:  J Womens Health (Larchmt)       Date:  2014-08-04       Impact factor: 2.681

6.  Cardiovascular risk in women after metabolic complications in pregnancy.

Authors:  A H E M Maas; A W J van 't Hof; M J de Boer
Journal:  Neth Heart J       Date:  2007-12       Impact factor: 2.380

7.  Pregnancy Complications and Later Development of Hypertension.

Authors:  Suttira Intapad; Barbara T Alexander
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-06-01

8.  Influence of maternal obesity on the association between common pregnancy complications and risk of childhood obesity: an individual participant data meta-analysis.

Authors:  Bernadeta Patro Golab; Susana Santos; Ellis Voerman; Debbie A Lawlor; Vincent W V Jaddoe; Romy Gaillard
Journal:  Lancet Child Adolesc Health       Date:  2018-09-07

9.  Gestational gut microbial remodeling is impaired in a rat model of preeclampsia superimposed on chronic hypertension.

Authors:  Jeanne A Ishimwe; Adesanya Akinleye; Ashley C Johnson; Michael R Garrett; Jennifer M Sasser
Journal:  Physiol Genomics       Date:  2021-01-25       Impact factor: 3.107

10.  Vagal withdrawal and sympathetic overactivity contribute to the genesis of early-onset pregnancy-induced hypertension.

Authors:  G K Pal; P Shyma; S Habeebullah; Pravati Pal; Nivedita Nanda; P Shyjus
Journal:  Int J Hypertens       Date:  2011-04-06       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.